Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers October 23, 2016
Pharmacy Choice - News - Front Page Healthcare News - October 23, 2016

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/23/16 - Insurance woes deepen after ACA
Recently, I received my 2017 health insurance enrollment information, and was astounded to see that my personal health insurance premium is again increasing by more than 20 percent. Since the Affordable Care Act was instituted, my monthly premium has increased well in excess of 100 percent. This would be fine if my deductible had declined, but that
10/23/16 - Investigators from CFD Research Corporation Report New Data on Clinical Trials and Studies (A New Level A Type IVIVC for the Rational Design of...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Research findings on Clinical Research- Clinical Trials and Studies are discussed in a new report. Our news editors obtained a quote from the research from CFD Research Corporation, "In response, long-acting injectables, which provide sustained drug release over longer periods
10/23/16 - Jubilant DraxImage Receives FDA Approval for RUBY-FILL Rubidium 82 Generator and Elution System
By a News Reporter-Staff News Editor at Heart Disease Weekly Jubilant DraxImage Inc.,, a wholly Owned Subsidiary of Jubilant Pharma Ltd, announced that the U.S. Food and Drug Administration has approved RUBY-FILL , an innovative technology for Positron Emission Tomography myocardial perfusion imaging. RUBY-FILL expands...
10/23/16 - New Heart Disease Study Results from Hospital Center Described (Coronary artery spasm and dobutamine stress echocardiography in patients without...
By a News Reporter-Staff News Editor at Heart Disease Weekly Investigators publish new report on Heart Disorders and Diseases- Heart Disease. According to news reporting originating in Belfort, France, by NewsRx journalists, research stated, "Given its high diagnostic and prognostic value and good safety profile, dobutamine stress echocardiograph
10/23/16 - Options for primary care doctors are shrinking [The Honolulu Star-Advertiser]
Oct. 23 Nearly a third of Oahu's primary care doctors are no longer accepting new patients. Many patients are left in limbo as their doctors retire, decline patients on Medicare or Medicaid the government health insurance programs for seniors and low-income residents or are unwilling to take on those with complicated medical problems due to n
10/23/16 - Private option water torture for GOP lawmakers
Voting for the private option was hard for many Arkansas Republican legislators, and every month- every dang month- it becomes harder to keep supporting it. The private option is the health care program created by the Legislature in 2013 after the U.S. Supreme Court ruled the Affordable Care Act- that's Obamacare- was constitutional but that states
10/23/16 - State Senate candidates respond to questions
Last week, the Watauga Democrat reached out to candidates running for election to the North Carolina Senate. What policies would you support to help facilitate wage growth and upward mobility in North Carolina? Do you support legislation that sets tuition rates or limits tuition increases at public universities in North Carolina?
10/22/16 - Agriculture Forum: What the new rules mean for you
Come Jan. 1, area farms both small and large, veterinarians and animal feed providers will see significant changes to antibiotic availability and use. The new Veterinary Feed Directive rules, under direction of the Food and Drug Administration address antimicrobials that are "medically Important," meaning drugs are important to both humans and anim
10/22/16 - CymaBay Therapeutics Announces that MBX-8025 has Received European Medicines Agency PRIority MEdicines (PRIME) Designation for the Treatment of Primary Biliary Cholangitis [Seven Days (United Arab Emirates)]
-CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced that MBX-8025 has been granted the PRIority MEdicine designation by the European Medicines Agency for the treatment of primary biliary cholangitis in patients who do not...
10/22/16 - FDA Approves Merck's ZINPLAVA? (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection (CDI) in Adult Patients Receiving Antibacterial Drug Treatment for CDI Who Are at High Risk of CDI Recurrence
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved ZINPLAVA? Injection 25 mg/mL. Merck anticipates making ZINPLAVA available in first quarter 2017.. For generations, Merck has been steadfast in its commitment to fighting infectious diseases and that commitment co
10/22/16 - Governor makes local appointments to state boards, commissions [Kuwait News Agency]
Paul Sophiea of Dearborn was appointed to the Michigan Board of Medicine. Housed within the Michigan Department of Licensing and Regulatory Affairs, the board oversees the practice of medicine and serves as the states licensing board. Nadra Shami of Dearborn was appointed to the PreK-12 Literacy Commission.
10/22/16 - Halloween contact lenses cause eye woes, experts say [Detroit Free Press]
Oct. 22 For some Halloween enthusiasts, eyes make the the costume, be it cat's eyes or scary alien peepers. The cheap nonprescription pairs sold over the counter at local malls and beauty-supply or costume stores are unregulated by the U.S. Food and Drug Administration, which oversees all medical devices in the U.S.. These costume contact lenses,
10/22/16 - Leaders debate over Medical Aid in Dying, ColoradoCare in CC event [The Gazette (Colorado Springs, Colo.)]
Oct. 22 Sides sparred Friday night over two ballot measures that have made national waves one, aiming to socialize Colorado's health insurance industry and the other, legalizing lethal prescriptions for terminal patients. The first debate addressed Proposition 106, a measure that would make Colorado one of just a handful of states that allow do
10/22/16 - Opening up clinical data on new medicines
LONDON, 20 October 2016/ PRNewswire Policy/ As of today, the European Medicines Agency gives open access to clinical reports for new medicines for human use authorised in the European Union. Vytenis Andriukaitis, European Commissioner for Health and Food Safety, said "Transparency is an essential component in clinical research. EMA's transparency
10/22/16 - Septic shock patients have better outcomes when their heart rates are lower, study finds
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Researchers at Intermountain Medical Center in Salt Lake City, along with researchers from four other centers, including Harvard Medical School, have found that patients with a lower heart rate who are in septic shock have a better chance of survival than those with an abnorm
10/22/16 - Supply Of Medical And Surgical Instruments For Interventional Radiology. [TendersInfo (India)]
Contract notice: Supply of medical and surgical instruments for interventional radiology. Open procedure for the supply of medical and surgical instruments for interventional radiology. Time limit for receipt of tenders or requests to participate: 24.11. 2016- 09:30.
10/22/16 - World's Smallest Pacemaker Licenced for Canadian Patients
-Medtronic Canada, a subsidiary of Medtronic plc, today announced it has received a Health Canada licence for the world's smallest pacemaker, the Medtronic Micra? Transcatheter Pacing System. The Micra TPS is the first Health Canada licenced product with miniaturized pacing technology. In November 2015, data from the Medtronic Micra TPS Global Cl
10/21/16 - AbbVie's New Oral Therapy VENCLEXTA Now Available For Canadians With A Difficult-To-Treat Blood Cancer
By a News Reporter-Staff News Editor at Drug Week AbbVie, a global biopharmaceutical company, announced Health Canada has issued a Notice of Compliance with Conditions for VENCLEXTA?. Under NOC/c policy, AbbVie will provide Health Canada with data from additional studies to confirm the clinical benefit of VENCLEXTA. It worked fine until I relap
10/21/16 - Addus HomeCare Corporation (NASDAQ:ADUS) Files An 8-K
Addus HomeCare Corporation (NASDAQ:ADUS), a provider of comprehensive home and community-based personal care services, today announced that it has named Susan T. Weaver, M.D., FACP, and Darin J. Gordon to its Board of Directors. Dr.Weaver serves as the Chief Executive Officer of healthcare services company, C3Healthcare Rx, and formerly served as
10/21/16 - Adherium Announces Key Technology Patent Granted in US [Emirates News Agency (WAM) (United Arab Emirates)]
-Adherium Limited, a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today announced that the US Patent and Trademark Office has granted a key patent covering medication adherence monitoring devices that include an optical dose counter. Through its SmartInhaler technology, Adherium pioneered
10/21/16 - Adimmune Successfully Places NT$1.5 BN Guaranteed Convertible Bonds
Taiwan- based vaccine provider Adimmune successfully placed NT$ 1.5 bn guaranteed convertible bonds due 2021. Adimmune's aseptic filling line has already obtained US cGMP certification, and the recombinant 4 strains seasonal flu vaccine, in collaboration with Protein Sciences Corporation, has been approved by US FDA. "We are very grateful for th
10/21/16 - AmerisourceBergen, More Than 500 Manufacturers Look to the Future of the Pharmaceutical Industry at ThinkLive 2016
During general session, AmerisourceBergen recognized several individuals and companies with a variety of awards, including the Shaping Healthcare Delivery award, which was given to UNC Healthcare. UNC Healthcare was recognized for its work in leveraging pharmacy to better support ongoing shifts in the continuum of care and deliver new value t
10/21/16 - Aralez to Acquire From AstraZeneca U.S. Rights to Beta Blocker Toprol-XL
By a News Reporter-Staff News Editor at Drug Week Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, announced it will acquire the U.S. rights to Toprol-XL and its Authorized Generic pursuant to an agreement entered into between AstraZeneca and Aralez Pharmaceuticals Trading DAC, a subsidiary of Aralez. It was first approv
10/21/16 - Big Pharma`s Getting Back Together with Medical Education [Tripoli Post, The (Libya)]
Despite a tenuous past relationship, the pharmaceutical industry is getting back together with continuing medical education events, according to new research published this week by business intelligence firm Cutting Edge Information. The pharmaceutical industry`s affiliation with medical education events has waxed and waned through the decades,...
10/21/16 - Braeburn Pharmaceuticals and Camurus announce the presentation of new data from clinical studies of long-acting buprenorphine
PRINCETON, N.J. and LUND, Sweden, Oct. 21, 2016/ PRNewswire/ Braeburn Pharmaceuticals and Camurus announce the presentation of new data from three clinical studies on CAM2038, an investigational long-acting injectable medication with flexible dosing, at a joint annual meeting of the International Society of Addiction Medicine and the Canadian Soc
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement